Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Eletriptan Hydrobromide

Known as: (R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole monohydrobromide, 3-(1-methyl-2-pyrrolidinylmethyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole hydrobromide, 3-[[(R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]indole, Monohydrobromide 
A triptan with specific affinity for the 5-hydroxytriptamine1B/1D receptor. Eletriptan hydrobromide binds to and acts at serotonin 5-HT1B receptors… Expand
National Institutes of Health

Related topics

Related topics

1 relation
eletriptan

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Thermoreversible nanoethosomal gel for the intranasal delivery of Eletriptan hydrobromide
The objective of the current study was to formulate and characterize thermoreversible gel of Eletriptan Hydrobromide for brain… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
2012
2012
Synthesis of compounds related to the anti-migraine drug eletriptan hydrobromide
Eletriptan hydrobromide (1) is a selective serotonin (5-HT1) agonist, used for the acute treatment of the headache phase of… Expand
2012
2012
METHOD DEVELOPMENT AND VALIDATION OF ELETRIPTAN HYDROBROMIDE TABLETS BY UV-VISIBLE SPECTROPHOTOMETRIC METHOD
Simple, accurate, precise, linear and reproducible method was developed for the estimation of Eletriptan hydrobromide… Expand
  • table 1
  • table 3
  • figure 1
  • figure 2
2010
2010
Perimenstrual Eletripan Prevents Menstrual Migraine: An Open‐Label Study
Objective.— To prospectively evaluate the efficacy of perimenstrual prophylaxis with eletriptan to reduce headaches in women… Expand
2010
2010
RP-HPLC Method for the Estimation of Eletriptan in Pharmaceutical Dosage Forms
A reverse phase high performance liquid chromatographic method has been described for the estimation of eletriptan in its… Expand
2009
2009
Study of forced degradation behavior of eletriptan hydrobromide by LC and LC-MS and development of stability-indicating method.
The objective of the present study was to report the stability profile of novel antimigrain drug Eletriptan hydrobromide based on… Expand
2006
2006
Eletriptan in Migraine Patients Reporting Unsatisfactory Response to Rizatriptan
Objective.—The objective of this open‐label study was to evaluate the efficacy of switching patients who had a previous… Expand
2006
2006
Validation of an HPLC method for the simultaneous determination of eletriptan and UK 120.413
Arapid and sensitive RPHPLCmethod was developed for the routine control analysis of eletriptan hydrobromide and its organic… Expand
  • figure 1
  • figure 2
  • table II
  • table III
  • table III
2000
2000
The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist.
The anti-migraine drug, eletriptan [(R)-3-(1-methyl-2-pyrrolidinylmethyl)-5-[2-(phenylsulphonyl )ethyl]-1 H-indole; UK-116,044… Expand
1998
1998
Retinal Degeneration in Rats Induced by CI-1010, a 2-Nitroimidazole Radiosensitizer
The anti-cancer compound CI-1010, designated as (R)-α-([(2-bromoethyl)amino]methyl)-2-nitro-]H-imidazole-l-ethanol… Expand
  • table I
  • table 11
  • figure 2
  • figure 3
  • figure 5
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE